Release Date: 31/01/19 19:24 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 271.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%